"Real-world experiences of first-line maintenance of PARP inhibitor treatment in non-BRCA mutant high-grade serous ovarian cancer" presented by Dr. Nicola Hannaway
For more information on the Gynecologic Cancer Initiative, please visit:
gynecancerinitiative.ca/ or email us at info@gynecancerinitiative.ca
Follow us on social media!
Twitter - bit.ly/3jsViHM
Instagram - bit.ly/3dRQsCF
Facebook - bit.ly/3knUgOw
Негізгі бет PARP inhibitor treatment in non-BRCA mutant high-grade serous ovarian cancer - Dr. Nicola Hannaway
Пікірлер